Detalles de la búsqueda
1.
M2 tumor-associated macrophages play important role in predicting response to neoadjuvant chemotherapy in triple-negative breast carcinoma.
Breast Cancer Res Treat
; 188(1): 37-42, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34032986
2.
HER2 intratumoral heterogeneity is independently associated with distal metastasis and overall survival in HER2-positive breast carcinomas.
Breast Cancer Res Treat
; 181(3): 519-527, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32335801
3.
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
BMC Cancer
; 20(1): 445, 2020 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32429929
4.
PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer.
Breast J
; 24(6): 911-919, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30230111
5.
HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.
Breast Cancer Res Treat
; 166(2): 447-457, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28799059
6.
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients.
Breast Cancer Res Treat
; 158(1): 99-111, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27318853
7.
Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.
Gastric Cancer
; 19(1): 63-73, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25487305
8.
The assessment of HER2 status in breast cancer: the past, the present, and the future.
Pathol Int
; 66(6): 313-24, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27061008
9.
A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity.
Gastric Cancer
; 18(3): 458-66, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24917219
10.
Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.
Histopathology
; 64(6): 826-39, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24251405
11.
HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept.
Cancers (Basel)
; 15(10)2023 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345001
12.
HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers.
Am J Clin Pathol
; 159(5): 464-473, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36857635
13.
Artificial intelligence reveals features associated with breast cancer neoadjuvant chemotherapy responses from multi-stain histopathologic images.
NPJ Precis Oncol
; 7(1): 14, 2023 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707660
14.
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.
Clin Cancer Res
; 29(16): 3101-3109, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37195235
15.
Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models.
Methods
; 52(4): 352-8, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20621192
16.
Predictive significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, for resistance to trastuzumab-based treatments for HER2-positive breast cancer.
Virchows Arch
; 479(1): 13-21, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33496805
17.
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.
Haematologica
; 95(4): 597-603, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20378577
18.
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
Haematologica
; 95(12): 2056-62, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20823132
19.
Breast HER2 Intratumoral Heterogeneity as a Biomarker for Improving HER2-Targeted Therapy.
Crit Rev Oncog
; 25(3): 233-240, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33463943
20.
Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer.
Hum Pathol
; 105: 9-19, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891647